Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death

BACKGROUND: Clinical studies have obtained inconsistent results of statin use on cancer outcomes. This study investigated the association between statin use and lung cancer mortality. RESULTS: The use of statin decreased mortality (hazard ratio = 0.91; 95% confidence interval: 0.86–0.96; P < .01)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wen-Yen, Li, Chia-Hsiang, Lin, Cheng-Li, Liang, Ji-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173128/
https://www.ncbi.nlm.nih.gov/pubmed/27283991
http://dx.doi.org/10.18632/oncotarget.9906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173128/
https://www.ncbi.nlm.nih.gov/pubmed/27283991
http://dx.doi.org/10.18632/oncotarget.9906

Ejemplares similares